Compounders Research Compare

Actuate Therapeutics Inc(ACTU)

Biotechnology · Fort Worth, TX

$0.81-0.07 (-7.99%)

Delayed quote: Oct 6, 2026, 9:59 AM EDT

About Actuate Therapeutics Inc

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.

Fort Worth, TX

12 employees

actuatetherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Daniel Schmitt

View full financials

Actuate Therapeutics (ACTU) Price/FCF Ratio: History & Chart | TGMCharts

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T14:00:19.059Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:00:19.059Z.

Quote observation: 2026-10-06T13:59:32.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 19,260,311
TTM free cash flow · period ending 2026-06-30: -19,836,208

FMP input reference: a29a88061d86e64317c53e71c63756e58f7ffa0b55551e6148327154cc786467

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ACTU Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

ACTU Competitors' Price/FCF Ratio

Actuate Therapeutics Inc

Current

Market Cap

$19.26M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cosmos Health Inc.

Market Cap

$19.02M

Price/FCF Ratio

N/A

TTM Avg

14.41

3Y Avg

40.25

5Y Avg

40.25

Estrella Immunopharma, Inc.

Market Cap

$18.87M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Dyadic International, Inc.

Market Cap

$17.19M

Price/FCF Ratio

N/A

TTM Avg

43.53

3Y Avg

55.71

5Y Avg

97.87

Lipocine Inc.

Market Cap

$17.07M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bionano Genomics, Inc.

Market Cap

$16.64M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aytu BioPharma, Inc.

Market Cap

$22.00M

Price/FCF Ratio

6.77

TTM Avg

13.56

3Y Avg

13.45

5Y Avg

13.45

BioCardia, Inc.

Market Cap

$16.49M

Price/FCF Ratio

N/A

TTM Avg

121.92

3Y Avg

75.43

5Y Avg

64.77

Allarity Therapeutics, Inc.

Market Cap

$15.75M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LeonaBio, Inc.

Market Cap

$22.80M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Actuate Therapeutics Inc (ACTU)	$19.26M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$19.02M	N/A	14.41	40.25	40.25
Estrella Immunopharma, Inc. (ESLA)vs ›	$18.87M	N/A	N/A	N/A	N/A
Dyadic International, Inc. (DYAI)vs ›	$17.19M	N/A	43.53	55.71	97.87
Lipocine Inc. (LPCN)vs ›	$17.07M	N/A	N/A	N/A	N/A
Bionano Genomics, Inc. (BNGO)vs ›	$16.64M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.00M	6.77	13.56	13.45	13.45
BioCardia, Inc. (BCDA)vs ›	$16.49M	N/A	121.92	75.43	64.77
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.75M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.80M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics